EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients

Lian Liu, Wenpu Lai, Xiaoling Zhuo, Sihui Chen, Xiaodan Luo, Huo Tan

Frontiers in Immunology · 2024

DOI: 10.3389/fimmu.2024.1437726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2024. Verfasst von Lian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Receptors, Immunologic, CD8-Positive T-Lymphocytes, Antigens, CD. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Leukemia is a prevalent pediatric life-threatening hematologic malignancy with a poor prognosis. Targeting immune checkpoints (ICs) to reverse T cell exhaustion is a potentially effective treatment for leukemia. Tissue resident memory T (T RM ) cells have been found to predict the efficacy of programmed death receptor-1 inhibitor (anti-PD-1) therapy in solid tumors. However, the IC characteristics of T RM cells in leukemia and their relationship with prognosis remain unclear.

Methods

We employed multi-color flow cytometry to evaluate the frequencies of CD103 + CD4 + and CD103 + CD8 + T cells in the peripheral blood (PB) of patients with acute myeloid leukemia and B-cell acute lymphoblastic leukemia compared to healthy individuals. We examined the expression patterns of PD-1 and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) within the circulating CD103 + T cell subsets affected by leukemia. To further elucidate the immunological landscape, we assessed the differentiation status of CD103 + T cells across various disease states in patients with leukemia.

Results

Our findings showed a significant increase in the frequency of CD103 + CD8 + T cells in the PB of patients with leukemia who had achieved complete remission (CR) compared to those in the de novo (DN) and relapsed/refractory (RR) stages. This increase was accompanied by a notable decrease in the expression levels of PD-1 and TIGIT in CD103 + CD8 + T cells in the CR stage. Additionally, our analysis revealed a higher proportion of CD103 + CD8 + T cells in the central memory (TCM) and effector memory (TEM) subsets of the immune profile. Notably, the proportions of CD103 + naïve T cells, CD103 + TEM, and CD103 + terminally differentiated T cells within the CD8 + T cell population were significantly elevated in patients with CR compared to those in the DN /RR stages.

Conclusion

The data indicate that circulating higher frequency of CD103 + CD8 + T cells with lower expression of PD-1 and TIGIT are associated with favorable outcomes in patients with leukemia. This suggests a potential role of T RM cells in leukemia prognosis and provides a foundation for developing targeted immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorReceptors, ImmunologicCD8-Positive T-LymphocytesAntigens, CDIntegrin alpha ChainsHumansMaleFemalePrognosisChildAdolescentChild, PreschoolLeukemia, Myeloid, AcuteMemory T CellsAdultImmunologic MemoryYoung AdultLeukemia

Stichwörter der Autor:innen

CD103+CD8+ T cellsPD-1T cell exhaustionTIGITimmune checkpointsleukemiatissue resident memory T cells

Substanzen

TIGIT protein, humanProgrammed Cell Death 1 ReceptorReceptors, ImmunologicAntigens, CDalpha E integrinsPDCD1 protein, humanIntegrin alpha Chains

Autor:innen und Institutionen

  • Guangzhou Medical University, Guangzhou, China.
  • Department of Hematology, Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Department of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, China.
  • Flow Morphology Group, Special Testing Technology Center, Guangzhou Huayin Medical Testing Center Special Testing Technology Center, Guangzhou, China.

Zitieren

APA

Liu, L., Lai, W., Zhuo, X., Chen, S., Luo, X., & Tan, H. (2024). Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1437726

Vancouver

Liu L, Lai W, Zhuo X, Chen S, Luo X, Tan H. Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients. Frontiers in Immunology. 2024. doi:10.3389/fimmu.2024.1437726

BibTeX
@article{Liu2024,
  author = {Liu, Lian and Lai, Wenpu and Zhuo, Xiaoling and Chen, Sihui and Luo, Xiaodan and Tan, Huo},
  title = {Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients},
  journal = {Frontiers in Immunology},
  year = {2024},
  doi = {10.3389/fimmu.2024.1437726}
}
Kostenlos starten →